Creative Medical Technology Holdings Inc (CELZ)

[NSX]

$CELZD... Imagine if it was delivered with a backbone, like this, for example:

Recent Business Highlights:
CaverStem® Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction (ED) in Men
140+ Patient trial (largest non-drug ED study) published in Journal of Translational Medicine
Numerous inquiries from healthcare professionals interested in becoming providers with three new providers committing in January and several more in advanced discussions
Record breaking kit orders in January from new and existing providers
Additional outreach to consumers and healthcare professionals underway showcasing groundbreaking results in publication via mailers, email, and trade advertising

To this:

Recent Business Highlights:
CaverStem® Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction (ED) in Men
140+ Patient trial (largest non-drug ED study) published in Journal of Translational Medicine proving that Caverstem is very safe, and very effective...give details of the published datda!

Exact number of inquiries from number of states healthcare professionals interested in becoming providers with three new providers committing in January and exact number from exact number of states more in advanced discussions
Record breaking kit orders in January from new and existing providers creating sufficient revenue to pay-off the upcoming # of note/loan and its due date off in full preventing and assuring reduction of dilution showcasing our commitment to our shareholders who have stood by us as we completed this reverse split. We promised that your patience will be rewarded, and we will continue to pay-off future upcoming notes assuring that revenues goes toward shareholder and company's best interest



Additional outreach to consumers and healthcare professionals underway showcasing groundbreaking results in publication via mailers, email, and trade advertising ----I can go on for a long while about what I wanted to see as their first post R/S PR, but …..